Acute Otitis Externa Clinical Trial
Official title:
A Phase 3, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study of the Comparative Efficacy and Safety of EXL CDOS in Subjects With Acute Otitis Externa
The purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when administered twice daily for 7 days.
This was a Phase 3, multicenter, randomized, double-blind, active-controlled, parallel-group study in adults and children (age 6 months and older) with a diagnosis of AOE with a 2-day screening period followed by a 2-week participation period. Subjects were administered study drug, EXL CDOS or RLD, 4 drops in the affected ear(s) BID for 7 days. The primary endpoint, the proportion of subjects with a clinical AOE score of 0, was measured at the TOC Visit on Day 15. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02918773 -
Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)
|
N/A | |
Not yet recruiting |
NCT04636957 -
A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)
|
Phase 3 | |
Completed |
NCT01447017 -
A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis
|
Phase 2 | |
Completed |
NCT01535599 -
Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
|
Phase 3 | |
Completed |
NCT02801370 -
Phase 3 Study of OTO-201 in Acute Otitis Externa
|
Phase 3 | |
Completed |
NCT00750633 -
A Phase III Study of an Otic Formulation in Acute Otitis Externa
|
Phase 3 | |
Terminated |
NCT00945802 -
FST-201 In The Treatment of Acute Otitis Externa
|
Phase 3 | |
Completed |
NCT03196973 -
Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa
|
Phase 3 | |
Recruiting |
NCT01584271 -
Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)
|
Phase 2 | |
Completed |
NCT00961675 -
FST-201 in the Treatment of Acute Otitis Externa
|
Phase 3 | |
Completed |
NCT01535560 -
Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
|
Phase 3 |